Theme: De Novo Advancements in Pharmaceutical Sciences

Asia Pharma 2016

Renowned Speakers

Asia Pharma 2016

ConferenceSeries Ltd is providing a great platform for thousands of pharmacists meet, learn, share and exchange views. We are concentrating on a view that everyone should gain from the conference. So, we are organizing plenary sessions, poster exhibitions and section programs, workshops at the conference.

Asia Pharma 2016 is supported with related journals and their editorial board members which provide a chance of meeting them, along with experts in Medicine, Pharmacological sciences and Pharmaceutical sciences.

Asia Pharma 2016 will be a great event where experts from universities, top Pharmaceutical industries, research centers and from the societies and association related to Pharmaceuticals gather and share their insights. So, all are whole heartedly invited to be a part of this conference.

  • 150+ Participation (70% Industry: 30% Academia)
  • 5+ Keynote Speakers
  • 30+ Plenary Speakers
  • 3+ Exhibitors
  • 20+ Innovative Educational Sessions
  • B2B Meetings
Why exhibit?
  • Make sales
  • Debut new products
  • Profile your brand
  • Meet new business partners and suppliers
  • Develop key relationships
  • Educate healthcare, pharma and biotech institutions and academia
Why you should attend?
  • Take part in the energizing occasion arrange, with round tables, boards, exhibits, speed organizing and numerous gathering tracks. 
  • Offer encounters, bits of knowledge and procedures in intuitive shared round tables. 
  • Hear more points of view in one place – from extensive medium and little associations from pharma, biotech and the scholarly community. 
  • Find how logical detailing progressions are being actualized by and by. 
  • Get to the core of why detailing and conveyance procedures fall flat. Analyze the difficulties before searching for solid arrangements.
  • Get to the core of why definition and conveyance methodologies come up short. Analyze the difficulties before searching for solid arrangements. 
  • Find how progresses in the area are affecting both substantial and little particle drugs. 
  • Investigate attempted and tried courses to enhance bioavailability
  • See how to build up the correct plan and conveyance system with a solid logical, clinical and business outlook. 
  • Find the most recent advancements in pharmaceutical sciences

Asia Pharma 2016 is distinguished with the attendance of Editorial Board Members of supported Journals, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who made this conference rewarding and fecund.

Pharmaceutical research work experienced tremendous growth in the past five years. In the next five years growth will increase to 40% as per the market value. Top Companies involved in the Pharmaceutical sales are Pfizer, Johnson & Johnson, Merck, Abbott, etc. from United States.
European countries also play major role in the sales of pharmaceutical products from companies like Novartis, GlaxoSmithKline, Astra Zeneca, French sanofi, Roche, etc.
There is rapid growth in the market and research environment in emerging economies such as Brazil, China and India, leading to a gradual migration of economic and research activities from Europe to these fast-growing markets. In 2012 the Brazilian and Chinese markets grew by 16% and 21% respectively compared to an average market growth of minus 2% for the five major European markets and minus 1% for the US market (source: IMS Retail Drug Monitor – February 2013).
In 2012 North America accounted for 41.0% of world pharmaceutical sales compared with 26.7% for Europe. According to IMS data, 62% of sales of new medicines launched during the period 2007-2011 were on the US market, compared with 18% on the European market.
In 2011 the pharmaceutical industry invested about € 29,200 million in R&D in Europe. A decade of strong US market dominance led to a shift of economic and research activity towards the US from 1995-2005. Additionally, Europe is now facing increasing competition from emerging economies: rapid growth in the market and research environments in countries such as Brazil and China are contributing to the move of economic and research activities to non-European markets. The geographical balance of the pharmaceutical market – and ultimately the R&D base – is likely to shift gradually towards emerging economies

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date July 11-13, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1 Day 2 Day 3
Poster Opportunity Closed Click Here to View